"Das MVZ am Küchwald ist eines der größten MVZ in Sachsen mit Standorten in Chemnitz und Burgstädt. Unsere Schwerpunkte sind die invasive und nichtinvasive kardiologische Diagnostik und Therapie. Als Tochterunternehmen der Klinikum Chemnitz gGmbH sind wir eng mit den ambulanten und stationären Strukturen des Krankenhauses der Maximalversorgung vernetzt. Unser eigenes Herzkatheterlabor verfügt über ambulante und belegärztliche Betten sowie eine Ambulanz für Kardiologie in Chemnitz mit Zweigstelle in Burgstädt. Unsere kardiologische Einheit ist zertifiziert als Weiterbildungsstätte für Kardiologie, interventionelle Kardiologie sowie als Chest-Pain-Unit, HFU-Schwerpunktpraxis und Brustschmerz-Ambulanz. Dabei blickt unser Unternehmen auf meh"

During the past decade, Medizinisches Versorgungszentrum am Küchwald GmbH conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medizinisches Versorgungszentrum am Küchwald GmbH" #1 sponsor was "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company" with 2 trials, followed by "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials sponsored, "ResMed" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "CVRx, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medizinisches Versorgungszentrum am Küchwald GmbH" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Medizinisches Versorgungszentrum am Küchwald GmbH" are "Heart Failure" (3 trials), "Atrial Fibrillation" (2 trials), "Hypercholesterolemia" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "Medizinisches Versorgungszentrum am Küchwald GmbH" in a lesser frequency.

Most popular intervention types in "Medizinisches Versorgungszentrum am Küchwald GmbH" are "Device" (5 trials), "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apabetalone" (1 trials), "Apixaban" (1 trials), "Atorvastatin" (1 trials), "Barostim Neo™ System" (1 trials) and "Bempedoic acid and/or its fixed-dose combination with ezetimibe" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medizinisches Versorgungszentrum am Küchwald GmbH" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Medizinisches Versorgungszentrum am Küchwald GmbH". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Medizinisches Versorgungszentrum am Küchwald GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medizinisches Versorgungszentrum am Küchwald GmbH, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".